VIASKIN® milk patch for EoE

PROGRAM & INDICATION
DEVELOPMENT STAGE
Discovery
Pre-Clinical
Phase 1
Phase 2
Phase 3
Food Allergy
VIASKIN® peanut patch
(DBV712)
Peanut Allergy
Discovery
Pre-Clinical
Phase 1
Phase 2
Phase 3
Ages 1-3 years and 4-7 years
Ages 1-3 years
Ages 4-7 years
Ages 4-11 years
Food Allergy
VIASKIN® milk patch
(DBV135)
Cow's Milk Allergy
Discovery
Pre-Clinical
Phase 1
Phase 2
Phase 3
Ages 2-17 years
Food Allergy
VIASKIN® milk patch
Eosinophilic Esophagitis*
Discovery
Pre-Clinical
Phase 1
Phase 2
Phase 3
Ages 4-17 years
Autoimmune & Inflammatory Disorders
Multiple Programs
Discovery
Pre-Clinical
Phase 1
Phase 2
Phase 3
Vaccines
Multiple Programs
Discovery
Pre-Clinical
Phase 1
Phase 2
Phase 3

*Early-stage development based on studies with VIASKIN® milk patch for cow’s milk allergy

Eosinophilic Esophagitis (EoE) is an allergic disease of the esophagus, most commonly triggered by cow’s milk. There are no currently approved FDA treatment options for the management of EoE.

DBV is exploring VIASKIN® milk patch for the treatment of cow’s milk-induced EoE in children.

External Collaborations

SMILEE (Study of Efficacy and Safety of VIASKIN® milk patch for Milk-induced EoE)

SMILEE was a double-blind, placebo-controlled, randomized phase 2a study sponsored by the Children’s Hospital of Philadelphia (CHOP) to assess the efficacy and safety of Viaskin Milk in cow’s milk-induced EoE. The study enrolled 20 subjects aged 4–17 years in the blinded period, of which 19 subjects were enrolled in the open-label extension.

Learn more

* VIASKIN® milk patch is an investigational product and has not been approved for any use in any country.

Scroll to Top